Can capmatinib be retaken within an hour?

Capmatinib (Capmatinib) is an oral small molecule mesenchymal epithelial transition (MET) factor tyrosine kinase receptor inhibitor. It is a targeted drug targeting MET gene mutations and is mainly used to treat non-small cell lung cancer (NSCLC). Regarding the taking time and refilling of this drug, patients should strictly follow the doctor's instructions and the recommendations in the drug package insert.

According to the instructions for use of capmatinib, the recommended dose is 400 mg taken orally twice daily (i.e. two 200 mg tablets), either before or after meals. It is important that patients take their medications at scheduled intervals to ensure stable concentrations of the drug in the body. If a patient misses a dose during a scheduled dosing schedule, the usual recommendation is to take it as soon as possible, but time constraints should be noted. Generally speaking, if it is more than an hour before the next dose, the patient can make up for the missed dose; if it is less than an hour before the next dose, the patient should skip the dose and take the next dose at the original time.

It needs to be particularly emphasized that when taking supplementary doses, do not take double doses to avoid excessive drug concentration and increase the risk of adverse reactions. Side effects of capmatinib may include abnormal liver function, gastrointestinal reactions, rash, etc. Therefore, maintaining a stable drug concentration is particularly important to reduce side effects and improve efficacy.

In practice, patients can set reminders to help them take their medications on time. In addition, it is very important to maintain communication with your doctor or pharmacist. If you have any questions or discomfort, you should consult a professional in time. In some cases, the doctor may adjust the medication plan according to the patient's specific condition, which also requires the patient's cooperation and understanding.